Brief: Opthea Seeks Trading Halt
16/03/2025 21:57
March 17 (Reuters) - Opthea Ltd OPT.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT ON TOP LINE RESULTS OF ITS PHASE 3 COAST CLINICAL TRIAL Further company coverage: OPT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceryvyn Therapeutics
See all newsBrief: Ceryvyn Therapeutics Posts FY Profit Attributable A$330.4 Million
Brief: Opthea To Recommence Trading On ASX On Or Around June 3, 2026
Brief: Opthea Says Hamish George Assumes Role Of CFO
Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln
Australia's Opthea cuts 80% staff, key executives to exit in deal to avert bankruptcy (updated)